Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: An in vivo microdialysis study

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 354, Issue 6, 1996, Pages 785-790

  Malagie, I ^a   Trillat, A C ^a   Douvier, E ^a   Anmella, M C ^a   Dessalles, M C ^a   Jacquot, C ^a   Gardier, A M ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

5 HT(1A) antagonist; Fluoxetine; Frontal cortex; Microdialysis; Serotonin; Ventral hippocampus

Indexed keywords

DRUG METABOLITE; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORFLUOXETINE; SEROTONIN; SEROTONIN 1A ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG TISSUE LEVEL; FRONTAL CORTEX; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; RAT;

EID: 0029805696     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00166906     Document Type: Article

References (0)